artus

artus is a biotechnology company that has been pioneering advanced DNA analytical procedures since its founding in 1998. Their primary focus is on PCR and real-time PCR technologies. The company is dedicated to enhancing diagnostic precision in infectious diseases, pharmacogenomics, and veterinary diagnostics. They specialize in the creation, manufacturing, and distribution of diagnostic kits using advanced DNA analysis techniques. Artus GmbH operates within the biotechnology and health care industries. The company's unique approach to diagnostic procedures has attracted attention from venture capital firms, although specific details about their last investment and the investors involved are currently unavailable. In conclusion, artus stands out as a forward-thinking company in the biotechnology sector, with a strong focus on leveraging advanced DNA analysis techniques to improve diagnostic accuracy in various vital areas of healthcare and veterinary medicine. Despite lacking specific information on recent investments, the company's innovative approach positions it positively for potential further funding and growth.